Product Images Azithromycin

Pharmacokinetic parameters for Tolain on Day 1 and Days (variable) are available. The parameters include Coa, T, AUCy 24, Cone, and urinary excretion. Azithromycin 250 mg tablets and capsules are bioequivalent in fasted state but capsules are no longer available commercially.*

The text describes the pharmacokinetic parameters for coadministered drugs in the presence of the drug Azithromycin, providing information on dose and ratio (with/without) of drug coadministered. The table provides data on several drugs, including torvastatin, carbamazepine, cetirizine, diganosine, efavirenz, fluconazole, indinavir, midazolam, neffinavir, and rifabutin. For some drugs, there is a significant effect on mean Cpmy and mean AUC in the presence of Azithromycin, while for others, there is no effect.*

This is a list of medical treatments and dosages, including drugs like Sildenafil, Theophylline, Imiglucerase, Triazolam, Trimethoprim/Sulfamethoxazole, and Zidovudine. The treatment durations range from 3 to 21 days. Rifabutin coadministration with azithromycin may result in 60 ng/mL concentration levels one-half day after the last dose. There is no information available on confidence intervals.*

This is a table showing drug interactions of Azithromycin when coadministered with other drugs, stating the dose of Azithromycin and the coadministered drug. Pharmacokinetic parameters with and without the coadministered drug are also shown, as well as a ratio of these parameters (with/without the coadministered drug). The table includes drugs such as Efavirenz, Fluconazole, Nelfinavir, and Rifabutin. However, there is not enough information to fully understand the data and its significance.*

Table 3 shows the criteria for interpreting susceptibility tests for Azithromycin. The table includes the minimum inhibitory concentrations (mcg/mL) and zone diameters in mm for pathogens such as Haemophilus influenzae, Staphylococcus aureus, and Streptococci. It is important to note that there is insufficient information available to determine intermediate or resistant interpretive criteria. Testing for susceptibility to azithromycin should be performed in ambient air.*

This is a table indicating acceptable quality control ranges for Azithromycin. The table contains minimum inhibitory disk diffusion concentrations for different strains of bacteria including Haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae. The strains' susceptibility to Azithromycin should be tested in ambient air. The text also abbreviates ATCC as American Type Culture Collection.*

This text provides data on the concentration of Azithromycin, an antibiotic drug, in various tissues and fluids of adults following a dose of 500mg (two capsules of 250mg each). The table shows the concentration of the drug in different tissues such as skin, lung, sputum, tonsil, and cervix at different time intervals after the dose. The data is based on samples obtained 2 to 4 hours and 10 to 12 hours after the first dose, and 19 hours after a single dose.*